The plaintiffs allege that the drugs caused them to develop non-arteritic anterior ischemic optic neuropathy, or NAION, a serious and irreversible condition
Further combining nutrition and exercise intervention, the strategies of GLP-1RAs in the comprehensive management of sarcopenia were explored.Finally, this paper points out the future research directions in this field, emphasizing the need for more well-designed and high-quality clinical studies to clarify the exact role, suitable population and long-term safety of GLP-1RAs in the prevention and treatment of sarcopenia
10.1016/s0014-2999(99)00486-0 54 KachlikD.BacaV.StinglJ
Given that our data show that more than half the patients taking GLP-1 medications earn less than $40,000 per year, this presents a financial challenge
L-carnitine operates downstream in mitochondria, shuttling stored fat into the cellular powerhouse where it burns for energy